The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
NCT01283958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2011-01-26
Summary
Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.
Conditions
- Eisenmenger's Syndrome
Sponsors & Collaborators
-
Gachon University Gil Medical Center
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Completion
- 2010-05-31
More Related Trials
-
Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction
NCT03620526 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After Surgery
NCT01310751 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
NCT00409526 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost
NCT00216931 ·Status: WITHDRAWN ·Phase: NA
-
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
NCT00086463 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
NCT00439543 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
NCT00120380 ·Status: TERMINATED ·Phase: PHASE4
-
Iloprost in High Risk Cardiac Surgical Patients
NCT00927654 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude
NCT00708565 ·Status: UNKNOWN ·Phase: PHASE1
-
Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome
NCT05611268 ·Status: RECRUITING ·Phase: NA
-
Effect of Intraoperative Iloprost Inhalant on Hemodynamic Stability in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery
NCT04598191 ·Status: UNKNOWN ·Phase: NA
-
Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
NCT00004754 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children
NCT03431649 ·Status: COMPLETED ·Phase: PHASE4
-
Iloprost for Bridging to Heart Transplantation in PH
NCT02482402 ·Status: WITHDRAWN ·Phase: PHASE2
-
VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB
NCT03122730 ·Status: COMPLETED ·Phase: PHASE2
-
Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)
NCT07263958 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Iloprost Power 15 in Pulmonary Arterial Hypertension
NCT00709956 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis
NCT00109681 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)
NCT01116063 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude
NCT00724321 ·Status: WITHDRAWN ·Phase: PHASE1
-
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
NCT00403650 ·Status: COMPLETED ·Phase: PHASE4
-
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure
NCT04420741 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation
NCT02490657 ·Status: COMPLETED ·Phase: NA
-
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
NCT00709098 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
NCT00453414 ·Status: WITHDRAWN ·Phase: PHASE2